Literature DB >> 10872649

Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.

H G Xie1, C M Stein, R B Kim, J V Gainer, G Sofowora, V Dishy, N J Brown, R E Goree, J L Haines, A J Wood.   

Abstract

BACKGROUND AND OBJECTIVES: The most common polymorphisms of the human beta2-adrenergic receptor--Arg16-->Gly and Gln27-->Glu--are associated with alterations in beta2-adrenergic receptor responses, both in vitro and in vivo. beta2-Adrenergic receptor-mediated vascular responses are affected by ethnicity, blood pressure, and genotype. We tested the hypothesis that these two common beta2-adrenergic receptor genetic variants are associated with essential hypertension in black or white Americans. SUBJECTS AND METHODS: In a population-based case-control association study, the relationship between beta2-adrenergic receptor genotypes and hypertension was examined in 307 normotensive subjects (128 black and 179 white) and 356 hypertensive subjects (155 black and 201 white). A polymerase chain reaction-based single-stranded conformational polymorphism method with direct sequencing of the bands of interest was used to detect the two frequently occurring beta2-adrenergic receptor variants (Arg16-->Gly, Gln27-->Glu).
RESULTS: No significant differences in the distributions of alleles and genotypes of the tested beta2-adrenergic receptor variants were found between normotensive and hypertensive groups from either black or white Americans (all P > .05). There was a marked interethnic difference in the frequency of the Gln27-->Glu beta2-adrenergic receptor polymorphism in both normotensive and hypertensive subjects. In normotensive white subjects, the variant Glu27 allele (35.2% versus 18.0%; P < .0001) and Glu27 homozygous genotype (14.0% versus 4.7%; P < .01) were more common than in black subjects. Similarly, in hypertensive white subjects, the variant Glu27 allele (35.8% versus 18.4%; P < .0001) and the Glu27 homozygous genotype (15.9% versus 2.6%; P < .0001) were more common than in black subjects.
CONCLUSIONS: These data suggest that although there are marked ethnic differences in their distribution, the common genetic polymorphisms of the human beta2-adrenergic receptor gene do not cosegregate with the presence of hypertension in either black or white Americans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10872649     DOI: 10.1067/mcp.2000.106293

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  19 in total

1.  Polymorphisms 'r us.

Authors:  S C Sealfon
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 2.  Genetic polymorphisms of adrenergic receptors.

Authors:  E M Garland; I Biaggioni
Journal:  Clin Auton Res       Date:  2001-04       Impact factor: 4.435

Review 3.  Beta-adrenoceptor polymorphisms.

Authors:  K Leineweber; R Büscher; H Bruck; O-E Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-28       Impact factor: 3.000

4.  Synopsis and data synthesis of genetic association studies in hypertension for the adrenergic receptor family genes: the CUMAGAS-HYPERT database.

Authors:  Georgios D Kitsios; Elias Zintzaras
Journal:  Am J Hypertens       Date:  2009-12-31       Impact factor: 2.689

5.  Beta-2 adrenoreceptor gene polymorphisms and sympathetic outflow in humans.

Authors:  Jens Tank; Karsten Heusser; Andre Diedrich; Dagmara Hering; Friedrich C Luft; Andreas Busjahn; Atakan Aydin; Janusz Limon; Krzysztof Narkiewicz; Jens Jordan
Journal:  Clin Auton Res       Date:  2011-03-30       Impact factor: 4.435

6.  Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans.

Authors:  Eric M Snyder; Kenneth C Beck; Niki M Dietz; John H Eisenach; Michael J Joyner; Stephen T Turner; Bruce D Johnson
Journal:  J Physiol       Date:  2005-12-08       Impact factor: 5.182

Review 7.  Genetics of arterial hypertension and hypotension.

Authors:  Dieter Rosskopf; Markus Schürks; Christian Rimmbach; Rafael Schäfers
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-30       Impact factor: 3.000

8.  Dietary sodium restriction and beta2-adrenergic receptor polymorphism modulate cardiovascular function in humans.

Authors:  John H Eisenach; Darrell R Schroeder; Tasha L Pike; Christopher P Johnson; William G Schrage; Eric M Snyder; Bruce D Johnson; Vesna D Garovic; Stephen T Turner; Michael J Joyner
Journal:  J Physiol       Date:  2006-06-01       Impact factor: 5.182

9.  Roles of beta2- and beta3-adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Authors:  Kazuko Masuo
Journal:  Int J Hypertens       Date:  2010-10-21       Impact factor: 2.420

10.  Relationship between the single nucleotide polymorphisms of β₂-adrenergic receptor 5'-regulatory region and essential hypertension in Chinese Kazakh ethnic minority group.

Authors:  Weijuan Cai; Liang Yin; Jiang Cheng; Shaoliang Wang; Yu Wei; Wenjiang Cao; Jiang Cheng
Journal:  Int J Clin Exp Pathol       Date:  2015-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.